Article info

Download PDFPDF

IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial

Authors

  1. Correspondence to Professor Gregory YH Lip; g.y.h.lip{at}bham.ac.uk
View Full Text

Citation

Shantsila E, Haynes R, Calvert M, et al
IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial

Publication history

  • Received April 12, 2016
  • Revised July 7, 2016
  • Accepted September 8, 2016
  • First published October 5, 2016.
Online issue publication 
October 05, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.